Early research (Phase 1)UnknownNCT02577458What this trial is testingStudy of the Combination of CM082 With Everolimus in Patients With mRCCWho this might be right forRenal Cell Carcinoma Recurrent AnewPharma 18
Not applicableStudy completedNCT01390519What this trial is testingA Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of AfinitorWho this might be right forMetastatic Renal Cell Carcinoma (mRCC) Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT03469713What this trial is testingNivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cancer Metastatic Gruppo Oncologico Italiano di Ricerca Clinica 69
Not applicableStudy completedNCT03891485What this trial is testingNivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve EfficacyWho this might be right forRCCMetastatic Renal Cell Carcinoma National Cancer Institute, Naples 200
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288What this trial is testingDynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) ScrambleWho this might be right forRenal Cell Carcinoma M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)WithdrawnNCT07011849What this trial is testingStudy of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain MetastasesWho this might be right forRenal Cell CarcinomaBrain Metastasis M.D. Anderson Cancer Center
Not applicableStudy completedNCT00684645What this trial is testingNon-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®Who this might be right forMetastatic Renal Cell Carcinoma Pfizer 186
Testing effectiveness (Phase 2)Looking for participantsNCT07188896What this trial is testingTrial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)Who this might be right forAdvanced Renal Cell Carcinoma (aRCC)Metastatic Renal Cell Carcinoma ( mRCC)Clear Cell Renal Cell Carcinoma (ccRCC) Brian Rini 120
Post-approval studies (Phase 4)Study completedNCT01514448What this trial is testingSafety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or PazopanibWho this might be right forMetastatic Renal Cell Carcinoma (mRCC) Novartis Pharmaceuticals 29
Large-scale testing (Phase 3)Study completedNCT01223027What this trial is testingStudy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Novartis Pharmaceuticals 564
Testing effectiveness (Phase 2)Ended earlyNCT06884683What this trial is testingNivolumab Plus Metformin in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Fondazione Policlinico Universitario Agostino Gemelli IRCCS 12
Testing effectiveness (Phase 2)UnknownNCT01274273What this trial is testingStudy of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma University of Aarhus 118
Early research (Phase 1)Study completedNCT03200587What this trial is testingCabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)Who this might be right forRenal Cell Carcinoma University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT03967522What this trial is testingEvaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain MetastasesWho this might be right forMetastatic Renal Cell Carcinoma Centre Leon Berard 26
Testing effectiveness (Phase 2)Study completedNCT00569946What this trial is testingStudy Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)Who this might be right forCarcinoma, Renal Cell Pfizer 64
Not applicableActive Not RecruitingNCT04919122What this trial is testingOutcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Duke University 468
Testing effectiveness (Phase 2)Study completedNCT01829841What this trial is testingFamitinib in Patients With Advanced Metastatic Renal Cell CancerWho this might be right forRenal Cell CancerMetastatic Renal Cell Cancer Jiangsu HengRui Medicine Co., Ltd. 150
Not applicableLooking for participantsNCT04659343What this trial is testingTDM for Optimized Outcome in Patients With mRCC.Who this might be right forKidney CancerRenal Cell Carcinoma MetastaticDrug Toxicity+2 more Niels Fristrup 200
Not applicableStudy completedNCT04076787What this trial is testingClinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line SunitinibWho this might be right forMetastatic Renal Cell Carcinoma Pfizer 1,769
Not applicableStudy completedNCT01934452What this trial is testingProspective Observational Analysis Of CR With Sunitinib Treatment In mRCC PatientsWho this might be right forComplete Remission in Renal Cell Carcinoma Pfizer 77